2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)-Reference-Cited by-同舟云学术

2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)

Published:2022-10-27 Issue:11 Volume:16 Page:E506-15
ISSN:1920-1214
Container-title:Canadian Urological Association Journal
language:
Short-container-title:CUAJ

Author:

Saad Fred,Aprikian Armen,Finelli Antonio,Fleshner Neil E.,Gleave Martin,Kapoor Anil,Niazi Tamim,North Scott A.,Pouliot Fréderic,Rendon Ricardo A.,Shayegan Bobby,Sridhar Srikala S.,So Alan I.,Usmani Nawaid,Vigneault Eric,Chi Kim N.

Publisher

Canadian Urological Association Journal

Subject

Urology,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of interventions for metastatic castration resistant prostate cancer (mCRPC) patients progressing on androgen receptor-axis-targeted (ARAT) therapy: a systematic literature review;Current Medical Research and Opinion;2024-08-27

2. Prostate carcinoma mimicking rectal cancer: a case report;Journal of Surgical Case Reports;2024-08-01

3. Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer;Heliyon;2024-06

4. A Real World Observational Study Characterizing Patients With Advanced Prostate Cancer Treated With or Without Androgen Receptor-Pathway-Inhibitor Therapies in Alberta, Canada;Clinical Genitourinary Cancer;2024-05

5. 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice;Current Oncology;2024-03-07